Position in AXGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,607,827
+$2,569,664 QoQ
Shares Held
78,715
+6650.9% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aquatic Capital Management LLC holds $72,444,028 across 22 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
985,535 | $42,062,633 | |
| 2 | ABT |
Abbott Laboratories
|
127,090 | $11,532,146 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
59,598 | $3,814,867 | |
| 4 | STE |
STERIS plc
|
16,627 | $3,501,147 | |
| 5 | ZBH |
Zimmer Biomet Holdings, Inc.
|
32,655 | $2,811,268 | |
| 6 | PODD |
Insulet Corp
|
16,200 | $2,466,450 | |
| 7 | ATEC |
Alphatec Holdings, Inc.
|
103,064 | $891,503 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
2,749 | $807,133 |
All Filings in AXGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,607,827 | 78,715 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,163 | 1,166 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,506 | 1,710 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,784 | 441 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $414,733 | 22,418 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $201,385 | 12,220 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $671,558 | 47,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $51,404 | 7,100 | Shares | Sole | 2024-08-14 | |
| 2022-12-31 | $87,824 | 8,800 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $3,748 | 400 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||